All In Biotech

Drug Trial Radar · NCT05818085

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

A Multicenter, Randomized, Double-blind, Controlled, Phase 2b/3 Study to Assess the Efficacy and Safety of ABP-671 in Participants With Gout

Last checked: Nov 19, 2026Latest source record: Dec 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Aug 11, 2023

Primary completion

Jan 30, 2025

Study completion Mar 30, 2025

Sponsor

Lead sponsor
Atom Therapeutics Co., LtdIndustry
Sponsor type
Industry
First posted
Apr 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 19 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare the efficacy and safety of different doses and regimens of ABP-671 with placebo and allopurinol. Part 2 of the study will compare the dosing regimen(s) of ABP-671 selected from Part 1 with placebo in participants who have not been enrolled for Part 1.

Conditions

  • Gout

Interventions

  • ABP-671Drug

    Low, medium or high dose (Part 1); Selected dose(s) (Part 2)

  • AllopurinolDrug

    Standard of care according to American College of Rheumatology (ACR) guideline for the management of gout

  • PlaceboOther

    ABP-671 matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants who achieve serum uric acid (sUA) levels <6.0 mg/dL (<0.360 mmol/L)Time frame: Week 28

Locations

57 sites in 5 countries. Site status is shown where the registry gives one.

  • Alliance for Multispecialty Research

    Tempe, Arizona

  • Tucson Neuroscience Research, LLC

    Tuscon, Arizona

  • Anaheim Clinical Trials (Cenexel ACT)

    Anaheim, California

  • Center for Clinical Trials of Sacramento

    Sacramento, California

  • Access Research Institute

    Brooksville, Florida

  • Nature Coast Clinical Reasearch

    Crystal River, Florida

  • JY Research Institute Inc.

    Cutler Bay, Florida

  • Accel Clinical Research Site

    DeLand, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Accel Research Sites Network - St. Pete-Largo Clinical Research Unit

    Largo, Florida

  • A & D Doctor Center

    Miami, Florida

  • Bioclinical Research Alliance

    Miami, Florida

  • Cordova Research Institute

    Miami, Florida

  • Century Research LLC

    Miami, Florida

  • ITB Research

    Miami, Florida

  • Combined Research Orlando Phase I-IV

    Orlando, Florida

  • New Horizons Research

    Palmetto Bay, Florida

  • Advanced Clinical Research of Atlanta

    Atlanta, Georgia

  • Centricity Research

    Columbus, Georgia

  • Alliance for Multispecialty Research, LLC.

    Newton, Kansas

  • DelRicht Research

    New Orleans, Louisiana

  • AMR

    New Orleans, Louisiana

  • Annapolis Internal Medicine/CCT Research

    Annapolis, Maryland

  • DelRicht Research of Gulfport

    Gulfport, Mississippi

  • Quality Clinical Research, Inc

    Omaha, Nebraska

  • Santa Rosa Medical Center

    Las Vegas, Nevada

  • Inspire Santa Fe Medical Group

    Santa Fe, New Mexico

  • OnSite Clinical Solutions

    Salisbury, North Carolina

  • DelRicht Research

    Tulsa, Oklahoma

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania

  • ClinSearch

    Chattanooga, Tennessee

  • Medical Care/CCT

    Elizabethton, Tennessee

  • PanAmerican Clinical Research, LLC

    Brownsville, Texas

  • Quality Research Inc.

    San Antonio, Texas

  • Centricity Research

    Suffolk, Virginia

  • Paratus Clinical Research Western Sydney

    Blacktown, New South Wales, Australia

  • Emeritus Research Sydney

    Botany, New South Wales, Australia

  • Paratus Clinical Research Central Coast

    Kanwal, New South Wales, Australia

  • A R Houston Medical Pty Ltd

    Kippa-Ring, Queensland, Australia

  • Emeritus Research Melbourne

    Camberwell, Victoria, Australia

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.